It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 04790cam 2200793Ia 4500
001 ocm52822879
003 OCoLC
005 20191104045614.0
008 030811s2003 dcu ob 000 0 eng d
006 m o d
007 cr cn|||||||||
040 $aN$T$beng$epn$cN$T$dOCLCQ$dYDXCP$dOCLCQ$dCOF$dOCLCQ$dACD$dOCLCQ$dTUU$dOCLCQ$dTNF$dOCLCQ$dGRPVE$dOCLCQ$dMERUC$dCCO$dE7B$dREDDC$dINU$dDKDLA$dNNM$dFVL$dOCLCO$dOCLCF$dNLGGC$dOCLCQ$dVAM$dEBLCP$dOCLCQ$dTOA$dMOR$dPIFBR$dZCU$dOCLCQ$dSAV$dOCLCQ$dOCLCO$dOCLCQ$dWY@$dOCLCQ$dOCLCO$dOCLCA$dM8D$dU3W$dOCLCO$dOCLCA$dROC$dOCLCO$dBUF$dOCLCO$dLUE$dOCLCO$dGILDS$dOCLCO$dHCC$dOCL$dRCC$dSTF$dWRM$dMNI$dCOCUF$dUAB$dNRAMU$dXOS$dMUO$dEZ9$dICG$dOCLCQ$dOCLCO$dINT$dVT2$dTOF$dOCLCQ$dOCLCO$dTKN$dWYU$dDKC$dOCLCQ$dUMK$dOCLCQ$dOCLCO$dOCLCQ
015 $aGBA315358$2bnb
016 7 $a0309086264$2Uk
019 $a70728154$a70769903$a326737524$a475383196$a531052771$a559112715$a646715509$a654541914$a722172185$a728004513$a923254962$a961612011$a962581619$a1028781119$a1055336377$a1063799736$a1081274343
020 $a0309503744$q(electronic bk.)
020 $a9780309503747$q(electronic bk.)
020 $z0309086264$q(pbk.)
020 $z9780309086264$q(pbk.)
035 $a(OCoLC)52822879$z(OCoLC)70728154$z(OCoLC)70769903$z(OCoLC)326737524$z(OCoLC)475383196$z(OCoLC)531052771$z(OCoLC)559112715$z(OCoLC)646715509$z(OCoLC)654541914$z(OCoLC)722172185$z(OCoLC)728004513$z(OCoLC)923254962$z(OCoLC)961612011$z(OCoLC)962581619$z(OCoLC)1028781119$z(OCoLC)1055336377$z(OCoLC)1063799736$z(OCoLC)1081274343
043 $an-us---
050 4 $aRA644.A6$bA87 2003eb
060 4 $aWC 305$bA846 2003
072 7 $aMED$x071000$2bisacsh
082 04 $a615/.372$221
245 03 $aAn assessment of the CDC anthrax vaccine safety and efficacy research program /$cCommittee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Medical Follow-up Agency, Institute of Medicine of The National Academies.
246 30 $aCDC anthrax vaccine safety and efficacy research program
260 $aWashington, DC :$bNational Academies Press,$c℗♭2003.
300 $a1 online resource (xvii, 160 pages)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
504 $aIncludes bibliographical references.
588 0 $aPrint version record.
505 0 $a1. Introduction -- 2. Background -- 3. The CDC anthrax vaccine research plan -- 4. Proposed studies on the efficacy of the anthrax vaccine -- 5. Proposed studies on the safety of the anthrax vaccine -- 6. Proposed studies on the acceptability of the anthrax vaccine -- 7. Summary assessment of the CDC anthrax vaccine research plan.
650 0 $aAnthrax$xVaccination$xResearch$zUnited States.
650 12 $aAnthrax$xprevention & control.
650 12 $aAnthrax Vaccines.
650 22 $aCenters for Disease Control and Prevention (U.S.)
650 22 $aDrug Evaluation.
650 22 $aProgram Evaluation.
651 2 $aUnited States.
650 7 $aMEDICAL$xPharmacology.$2bisacsh
651 7 $aUnited States.$2fast$0(OCoLC)fst01204155
655 4 $aElectronic books.
710 2 $aInstitute of Medicine (U.S.).$bCommittee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program.
776 08 $iPrint version:$tAssessment of the CDC anthrax vaccine safety and efficacy research program.$dWashington, DC : National Academies Press, ℗♭2003$z0309086264$w(OCoLC)51303124
856 40 $3ebrary$uhttp://site.ebrary.com/id/10038570
856 40 $3EBSCOhost$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=86870
856 40 $3National Academies Press$uhttp://www.nap.edu/catalog.php?record_id=10527
856 40 $3National Academies Press$uhttp://www.nap.edu/catalog/10527.html
856 40 $3National Academies Press$uhttp://www.nap.edu/books/0309086264/html/
856 40 $3National Academies Press$uhttp://www.nap.edu/openbook.php?record_id=10527
856 40 $3ProQuest Ebook Central$uhttps://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=3375300
856 40 $uhttp://www.ncbi.nlm.nih.gov/books/NBK221080/$zConnect to NCBI e-book
856 40 $uhttp://VH7QX3XE2P.search.serialssolutions.com/?V=1.0&L=VH7QX3XE2P&S=JCs&C=TC0000106797&T=marc&tab=BOOKS
938 $aProQuest Ebook Central$bEBLB$nEBL3375300
938 $aebrary$bEBRY$nebr10038570
938 $aEBSCOhost$bEBSC$n86870
938 $aYBP Library Services$bYANK$n2292847
029 1 $aAU@$b000051316020
029 1 $aDEBBG$bBV043068885
029 1 $aDEBBG$bBV044106015
029 1 $aDEBSZ$b422422770
029 1 $aGBVCP$b801053978
029 1 $aNZ1$b11772334
029 1 $aNZ1$b14258514
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 1653 OTHER HOLDINGS